Administration of a CD31-derived peptide reduces lethal graft-versus-host disease across the minor histocompatibility complex barrier in mice Chen, Y., Schlegel, P. G., Tran, N., Thompson, D., Zehnder, J. L., Chao, N. J. AMER SOC HEMATOLOGY. 1995: 2286–86

View details for Web of Science ID A1995TH91002287